
Keywords: Fluoxetine; Neurodevelopmental disorders; Impulsivity; Metabolomics; Fibroblasts; Biomarkers5HTTLPR, Serotonin transporter length polymorphic region; AICAR, 5-Aminoimidazole-4-carboxamide ribonucleotide; ASD, Autism spectrum disorders; CSF, Cerebrospinal